auto
Find a product
Browse other companies

BioLegend

Go to vendor site
cst@biolegend.com
1-858-455-9588
1-877-246-5343

Featured product reviews

4 - Excellent (Publishable / Ideal reagent)
Application: FACS
Sample: enriched human peripheral blood DCs
Buffer: 2% human serum, 0.5 mM EDTA in PBS
Dilution: 1/1000
4 - Excellent (Publishable / Ideal reagent)
Application: FACS
Sample: enriched human peripheral blood DCs
Buffer: Gated on lymphocyte FSC-A and SSC-A populations. Singlets were further gated on by FSC-A/FSC-H doublet exclusion. Suboptimal dilution. Optimal dilution at 1/100-1/250.
Dilution: 1/500
4 - Excellent (Publishable / Ideal reagent)
Application: FACS
Sample: enriched human peripheral blood DCs
Buffer: 2% human serum, 0.5 mM EDTA in PBS
Dilution: 1/250
4 - Excellent (Publishable / Ideal reagent)
Application: FACS
Sample: Lymph node lymphocytes - mouse (C57BL/6)
Buffer: PBS + 2% FBS
Dilution: 1:100

Product verified in publication

Custom services

  • Custom Conjugation Service
  • Monoclonal and Polyclonal Antibody Production
See all services (2) »

Selected service reviews

  • Rating: 4.00
  • Service provided
    approx. 5 years 2 months ago
  • Value for money: 4
  • Timeline: 4
  • Communications / Customer Service: 4
  • Overall quality: 4

About BioLegend

BioLegend develops world-class, cutting-edge antibodies and reagents for biomedical research, manufactured in our state-of-the-art facility in San Diego, CA. Our mission is to accelerate research and discovery by providing the highest quality products at an outstanding value, along with superior customer service and technical support. Our product areas include cell immunophenotyping, cytokines and chemokines, adhesion, cancer research, T regulatory cells, stem cells, innate immunity, cell-cycle analysis, apoptosis, and modification-specific antibodies. All of BioLegend's reagents are supported by superior customer service and come with a quality guarantee. Our aggressive product development program, through technology licensing, collaborations, and internal hybridoma development, produces strategic reagents for use in a variety of applications.